Kiyoshi Ando

Hiroshima University — Japan

Medicine · Health Sciences

58h-index15.7kcitations542works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(128), Chronic Lymphocytic Leukemia Research(82), Hematopoietic Stem Cell Transplantation(53), Viral-associated cancers and disorders(45), Immune Cell Function and Interaction(43)

Publications541 total

Impact of Achieving Progression‐Free Survival 24 on Subsequent Overall Survival in Diffuse Large B‐Cell Lymphoma Patients
Cancer Science·2025Open Access
Final results of JCOG0601 randomized trial of R-CHOP versus CHOP combined with dose-dense rituximab for diffuse large B-cell lymphoma
Japanese Journal of Clinical Oncology·2025
Protocol for a multicentre, open-label, dose-escalation phase I/II study evaluating the tolerability, safety, efficacy and pharmacokinetics of repeated continuous intravenous PPMX-T003 in patients with aggressive natural killer cell leukaemia
BMJ Open·2025Open Access
Tablet Screen-Touch Behavior with Audiovisual Stimulus Consequences in the Common Marmoset (Callithrix Jacchus)
International Journal of Comparative Psychology·2025Open Access
Prognostic impact of RDI of vincristine in patients with DLBCL receiving R-CHOP: a supplementary analysis of JCOG0601
Blood Neoplasia·2025· 2 citedOpen Access
Interaction of SARS-CoV-2 Spike protein with ACE2 induces cortical actin modulation, including dephosphorylation of ERM proteins and reduction of cortical stiffness
Human Cell·2024
A single microRNA miR-195 rescues the arrested B cell development induced by EBF1 deficiency
2024Open Access
A single microRNA miR-195 rescues the arrested B cell development induced by EBF1 deficiency
eLife·2024Open Access
Tazemetostat for relapsed/refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan: 3-year follow-up for a phase II study
International Journal of Hematology·2024· 7 citedOpen Access
A single microRNA miR-195 rescues the arrested B cell development induced by EBF1 deficiency
2024Open Access
Amino acid influx via LAT1 regulates iron demand and sensitivity to PPMX-T003 of aggressive natural killer cell leukemia
Leukemia·2024· 4 citedOpen Access
Long-term efficacy and safety of tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: final analysis of phase IIb results
Haematologica·2024· 1 citedOpen Access
Mutations in the SARS-CoV-2 spike proteins affected the ACE2-binding affinity during the development of Omicron pandemic variants
Biochemical and Biophysical Research Communications·2024· 9 cited
Unique lipid composition maintained by extracellular blockade leads to prooncogenicity
Cell Death Discovery·2024· 4 citedOpen Access
Plasminogen activator inhibitor-1 promotes immune evasion in tumors by facilitating the expression of programmed cell death-ligand 1
Frontiers in Immunology·2024· 33 citedOpen Access
Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first‐line treatment: A 15‐year follow‐up of patients with advanced follicular lymphoma in JCOG0203
Hematological Oncology·2024· 2 citedOpen Access
A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia
International Journal of Hematology·2024· 6 citedOpen Access
Author response for "Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first‐line treatment: A 15‐year follow‐up of patients with advanced follicular lymphoma in JCOG0203"
2024
Clostridium butyricum MIYAIRI 588 contributes to the maintenance of intestinal microbiota diversity early after haematopoietic cell transplantation
Bone Marrow Transplantation·2024· 10 citedOpen Access
Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy – a supplementary analysis of JCOG0601
Annals of Hematology·2024· 2 citedOpen Access
page 1 of 28Next →

Frequent Co-authors

Tomomitsu Hotta(19), Shunichi Kato(11), Kensei Tobinai(9), Hiroshi Kawada(8), Daisuke Sakai(8), Joji Mochida(8), Yoshihiko Nakamura(7), Takashi Yahata(7), Yukari Muguruma(6), Hideyuki Okano(6), Michinori Ogura(6), Kenichi Ishizawa(5), Toru Iwashina(5), Naokuni Uike(5), Irit Avivi(5), Jun Fujita(4), Hiroko Miyatake(4), Keiichi Fukuda(4), Tomoko Nakai(4), Masafumi Taniwaki(4)